Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  American Journal of Physiology

• Publication date

  1985-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/AJPGI.1985.248.6.G618PMID 4003545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hemodynamic Changes in Patients with Portal Venous Obstruction

  2007cited by this paper
• Chronic Bile Duct Ligation in the Dog: Hemodynamic Characterization of a Portal Hypertensive Model

  2007cited by this paper
• The Relationship Between Prostacyclin Activity and Pressure in the Portal Vein

  2007cited by this paper
• Increased portal venous resistance hinders portal pressure reduction during the administration of β‐adrenergic blocking agents in a portal hypertensive model

  1985cited by this paper
• Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.

  1984cited by this paper
• Increased blood flow through the portal system in cirrhotic rats.

  1984cited by this paper
• Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat.

  1984cited by this paper
• Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.

  1983cited by this paper
• Splanchnic hemodynamics in portal-hypertensive rats: measurement with gamma-labeled microspheres.

  1982cited by this paper
• Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis.

  1982cited by this paper
• Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

  1981cited by this paper
• Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

  1980cited by this paper
• Reference sample microsphere method: cardiac output and blood flows in conscious rat.

  1980cited by this paper
• Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis

  1979cited by this paper
• Insulin and glucagon levels in liver cirrhosis

  1979cited by this paper
• Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

  1978cited by this paper
• Self-established porto-caval and porto-pulmonary shunts in mechanically induced portal hypertension. An experimental study.

  1978cited by this paper
• The porto-systemic collateral pattern in the rat. An angiographic and anatomical study after partial occlusion of the portal vein.

  1974cited by this paper
• Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.

  1974cited by this paper
• Elevated plasma glucagon levels in cirrhosis of the liver.

  1973cited by this paper
• Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease.

  1972cited by this paper
• Portal blood flow in cirrhosis of the liver.

  1967cited by this paper
• The effects of glucagon on systemic and hepatosplanchnic haemodynamics and on net peripheral and hepatosplanchnic balance of glucose, lactic and pyruvic acids in normal subjects and cirrhotics.

  1966cited by this paper
• GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER.

  1964cited by this paper
• Myogenic Nature of Increase in Intestinal Vascular Resistance with Venous Pressure Elevation

  1959cited by this paper
• Circulatory changes in chronic liver disease.

  1958cited by this paper

• Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.

  2024cites this paper
• Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease

  2023cites this paper
• The sympathetic nervous system promotes hepatic lymphangiogenesis, which is protective against liver fibrosis.

  2023cites this paper
• Synergistic antioxidant and anti-inflammatory action of N-acetylcysteine in portal hypertensive gastropathy in rats

  2022cites this paper
• Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats

  2022cites this paper
• CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATS

  2020cites this paper
• Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension

  2020cites this paper
• Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes

  2020cites this paper
• Pathophysiology of Portal Hypertension

  2020cites this paper
• Mechanism and Pathophysiology of Portal Hypertension

  2019cites this paper
• Animal models of portal hypertension.

  2019cites this paper
• INVOLVEMENT OF CATECHOLAMINES IN THE MYOCARDIUM OF RATS SUBMITTED TO EXPERIMENTAL MODEL OF PORTAL HYPERTENSION

  2018cites this paper
• Hepatobiliary Diseases in the Cancer Patient Leading to Critical Illness

  2018cites this paper
• The portal hypertension syndrome: etiology, classification, relevance, and animal models

  2018cites this paper
• Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

  2017cites this paper
• Glutamine prevents oxidative stress in a model of portal hypertension

  2017cites this paper
• Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats

  2017cites this paper
• Portopulmonary Hypertension and Hepatopulmonary Syndrome

  2017cites this paper
• Inflammatory bowel and oxidative stress changes in an experimental model of portal hypertension: action of N-acetylcysteine

  2016influential citation
• Beta blockers in cirrhosis: The window re-opens.

  2016cites this paper
• nflammatory bowel and oxidative stress changes n an experimental model of portal hypertension : ction of N-acetylcysteine

  2016influential citation
• Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis

  2016cites this paper
• Редакционная статья Применение β-блокаторов при циррозе печени : второе окно

  2016cites this paper
• splanchnic circulation in portal hypertensive rats NO overproduction by eNOS precedes hyperdynamic

  2016cites this paper
• 2'‐Hydroxyflavanone ameliorates mesenteric angiogenesis and portal‐systemic collaterals in rats with liver fibrosis

  2016cites this paper
• Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders

  2016cites this paper
• РЕМАКСОЛ: МЕХАНИЗМЫ ДЕЙСТВИЯ И ПРИМЕНЕНИЕ В КЛИНИЧЕСКОЙ ПРАКТИКЕ. Часть 2

  2016cites this paper
• Choosing an Optimal Suture Material for Prehepatic Portal Hypertension Modeling

  2016cites this paper
• Non-Invasive Measurement of Systemic Haemodynamics by Finometry in Patients with Cirrhosis

  2015cites this paper
• Pharmacological Treatment in Upper Gastrointestinal Bleeding

  2015cites this paper
• Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.

  2015influential citation
• Alteration of intrahepatic microcirculation in cirrhotic livers

  2015cites this paper
• AVALIAÇÃO DA TROMBOCITOPENIA E ENVOLVIMENTO DA ESPLENOMEGALIA EM RATOS SUBMETIDOS AO MODELO DE HIPERTENSÃO PORTAL

  2015cites this paper
• Arachidonic acid metabolites and endothelial dysfunction of portal hypertension.

  2015cites this paper
• N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.

  2015cites this paper
• Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis

  2014cites this paper
• Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats.

  2014cites this paper
• Effect of laparoscopic abdominal surgery on splanchnic circulation: historical developments.

  2014cites this paper
• Beta-Blockers for All … or Not

  2014cites this paper
• Constriction rate variation produced by partial ligation of the portal vein at pre-hepatic portal hypertension induced in rats

  2014cites this paper
• Hémostase et cirrhose

  2014cites this paper
• A new model for the study of secondary intra-abdominal hypertension in rats.

  2014cites this paper
• Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.

  2013cites this paper
• Ação da N-acetilcisteína (NAC) na gastropatia da hipertensão portal

  2013cites this paper
• Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats

  2013influential citation
• Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: Role of dimethylarginine dimethylaminohydrolase

  2013cites this paper
• Increase in spleen volume of rats on experimental model of pre-hepatic portal hypertension.

  2013cites this paper
• Aumento do volume do baço em modelo experimental de hipertensão portal pré-hepática em ratos

  2013cites this paper
• Effects of portal hypertension on contractility of rat spleen.

  2013cites this paper
• Chronological changes in renal vascular reactivity in portal hypertensive rats

  2013cites this paper
• Selective cyclooxygenase‐1 inhibition improves collateral vascular reactivity in biliary cirrhotic rats

  2013cites this paper
• Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis

  2012cites this paper
• Current Perspectives in Hepatology

  2012cites this paper
• Current Clinical Needs

  2012cites this paper
• Characteristics and natural history of gastric varices in portal hypertension.

  2012cites this paper
• Hipertensión portal: desarrollo de una respuesta inflamatoria sistémica asociada a síndrome metabólico

  2012cites this paper
• Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats

  2012cites this paper
• A glutamina protege a mucosa gástrica dos danos na gastropatia da hipertensão portal

  2012influential citation
• Mechanisms and Consequences of Portal Hypertension

  2012cites this paper
• Disorders of Sodium Balance

  2012cites this paper
• Endothelin‐1 derived from spleen‐activated Rho‐kinase pathway in rats with secondary biliary cirrhosis

  2012cites this paper
• Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy.

  2011cites this paper
• Portal vein thrombosis

  2011cites this paper
• Multiple organ inflammatory response to portosystemic shunt in the rat.

  2011cites this paper
• A Novel Canine Model of Portal Vein Stenosis Plus Thioacetamide Administration-Induced Cirrhotic Portal Hypertension With Hypersplenism

  2011cites this paper
• Hyperdynamic circulation and portal hypertension: chicken or egg?

  2011cites this paper
• Gut-Brain Chemokine Changes in Portal Hypertensive Rats

  2011cites this paper
• Protection of estrogen in portal hypertension gastropathy: an experimental model.

  2011cites this paper
• O envolvimento do estrogênio no estresse oxidativo induzido pela ligadura parcial da veia porta em ratas Wistar

  2011cites this paper
• Hemodynamic Assessment of the Development of Portal-Systemic Collaterals in Portal Hypertensive Rats

  2011cites this paper
• Implicació de l’angiogènesi en la patofisiologia de la hipertensió portal

  2010cites this paper
• Bacterial Translocation to Mesenteric Lymph Nodes Increases in Chronic Portal Hypertensive Rats

  2010cites this paper
• A canine portal hypertension model induced by intra‐portal administration of Sephadex microsphere

  2010cites this paper
• Physiopathology of splanchnic vasodilation in portal hypertension.

  2010cites this paper
• The Gastrointestinal Circulation

  2010cites this paper
• Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases.

  2009cites this paper
• EVOLUTION OF PORTAL-SYSTEMIC COLLATERAL VASOPRESSIN RESPONSE IN ENDOTOXEMIC PORTAL HYPERTENSIVE RATS

  2009cites this paper
• Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.

  2009cites this paper
• Stability of a rat model of prehepatic portal hypertension caused by partial ligation of the portal vein.

  2009cites this paper
• Intestine as source of cytokines and growth factors.

  2009cites this paper
• Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.

  2008cites this paper
• Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat.

  2008cites this paper
• Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis

  2008cites this paper
• ASPECTE ALE PATOGENIEI HIPERTENSIUNII PORTALE. MODIFICĂRI ALE HEMOCIRCULAŢIEI PORTALE LA BOLNAVUL CIROTIC (revista literaturii) THE ASPECTS OF PORTAL HYPERTENSION PATOGENESIS. MODIFICATIONS OF PORTAL HEMOCIRCULATION IN CIRRHOTIC PATIENT

  2008cites this paper
• Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.

  2008cites this paper
• Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats.

  2008cites this paper
• PAPEL DE LAS DIMETILARGININAS EN LA HIPERTENSIÓN PORTAL Y CIRROSIS EXPERIMENTAL

  2008cites this paper
• Splanchnic-Brain Crosstalk Mediated By Chemokines In Portal Hypertensive Rats

  2008cites this paper
• Desarrollo y validación de un modelo experimental de encefalopatía hepática en ratas con ascitis. Efectos de la administración de IGF-1 frente a rifaximina en este modelo experimental

  2008cites this paper
• Defective endothelial nitric oxide synthase signaling is mediated by rho‐kinase activation in rats with secondary biliary cirrhosis

  2008cites this paper
• Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.

  2008cites this paper
• Hemodynamic changes in visceral organs following closed head trauma in rats.

  2008cites this paper
• Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

  2007cites this paper
• Partial Portal Vein Ligation Plus Thioacetamide: A Method to Obtain a New Model of Cirrhosis and Chronic Portal Hypertension in the Rat

  2007cites this paper
• Evolutive phases of experimental prehepatic portal hypertension

  2007cites this paper
• Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.

  2007cites this paper
• Increased neuronal nitric oxide synthase interaction with soluble guanylate cyclase contributes to the splanchnic arterial vasodilation in portal hypertensive rats

  2007cites this paper
• Hemodynamic Evaluation Before Liver Transplantation: Insights Into the Portal Hypertensive Syndrome

  2007cites this paper
• Splanchnic and systemic vasodilation: the experimental models.

  2007cites this paper
• Chronic Indomethacin Treatment Enhances the Portal‐systemic Collateral Vascular Response to Vasopressin in Bile‐duct Ligated Rats

  2007cites this paper